10 completed. 10 Phase 1.
By phase and status
Follow PF-05089771: new trials by email Literature Review of PF-05089771 trials Research Report on PF-05089771
Trials (filtered) newest first · largest first
All 10 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Assessment of the Analgesic Effects of PF-05089771 and Pregabalin in Healthy Volunteers Using Evoked Pain Endpoints
PF-05089771 300mg, PF-05089771 300 mg + pregabalin 300 mg, Placebo - Healthy | Phase 1 | Completed | 25 | 2015-01-01 | 2015-04-23 |
Drug-Drug Interaction Study With PF-05089771
Pravastatin, midazolam, losartan, omeprazole, caffeine and PF-05089771 - Healthy | Phase 1 | Completed | 17 | 2013-09-01 | 2014-01-16 |
Relative Bioavailability With PF-05089771 Capsule Versus Oral Dispersion
PF-05089771 - Healthy | Phase 1 | Completed | 12 | 2013-05-01 | 2013-06-25 |
Safety And Tolerability Study Of BID Titration Scheme With PF-05089771
PF-05089771, Placebo - Healthy | Phase 1 | Completed | 40 | 2013-01-01 | 2013-05-10 |
A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted State
PF-05089771 - Pain | Phase 1 | Completed | 12 | 2012-09-01 | 2012-12-12 |
A Study Comparing PF-05089771 TS Tablet to PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And Fed State
PF-05089771 - Pain | Phase 1 | Completed | 12 | 2012-02-01 | 2012-03-27 |
A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee
PF-05089771 - Pain | Phase 1 | Completed | 80 | 2012-01-01 | 2012-12-12 |
The Safety and Tolerability of PF-05089771 Will be Investigated in Healthy Subjects Over a 14 Day Dosing Period.
PF-05089771 - Pain | Phase 1 | Completed | 30 | 2011-06-01 | 2011-10-06 |
A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy Volunteers
PF-05089771 - Pain | Phase 1 | Completed | 61 | 2010-12-01 | 2012-02-02 |
To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity
PF-05186462, PF-05089771, PF-05150122 - Healthy | Phase 1 | Completed | 40 | 2010-07-01 | 2010-08-24 |
Conditions studied
Pain (5) · Chronic Pain (1)
Sponsors
Pfizer (10)
Countries
Belgium (7) · Netherlands (1) · United Kingdom (1) · United States (1)
NIH funding
2014 (1)